By Metro US
Posted on
RIO DE JANEIRO (Reuters) – Pfizer Inc has delivered the results of the Phase 3 trial for its COVID-19 vaccine to Brazilian health regulator Anvisa, the regulatory body said in a statement on Wednesday.
Pfizer is the second company to do so after AstraZeneca Plc delivered its results to Anvisa earlier in December.
(Reporting by Pedro Fonseca; Writing by Gram Slattery; Editing by Brad Haynes)
Liverpool’s Premier League title hopes hit by 2-0 loss to Everton. Man United survives another scare
Cubs OF Cody Bellinger sidelined by two fractured ribs on his right side
Ex-minor league umpire sues MLB, says he was harassed by female ump, fired for being bisexual man
Mbappe nets twice in win over Lorient but PSG’s title party delayed by Monaco victory
Lindor slugs 2 home runs, Mets end 3-game skid with 8-2 win over Giants
Biden pardons 11 people and shortens the sentences of 5 others convicted of non-violent drug crimes
Key moments in the Supreme Court’s latest abortion case that could change how women get care
Biden meets 4-year-old Abigail Edan, an American who was held hostage by Hamas
Hamas releases video showing well-known Israeli-American hostage
Meta more than doubles Q1 profit but revenue guidance pulls shares down after-hours
Relatives of those who died waiting for livers at now halted Houston transplant program seek answers
Jill Biden launches bike ride for wounded service members, stresses need to support vets
Gov. Gavin Newsom wants to let Arizona doctors provide abortions in California
More cows are being tested and tracked for bird flu. Here’s what that means
